Coronavirus-19, Covid-19, pandemic

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19

DocWire News Featured Reading
18 February 2022
https://www.docwirenews.com/abstracts/repurposing-low-dose-naltrexone-ldn-for-the-prevention-and-treatment-of-immunothrombosis-in-covid-19/